Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
762.980.17%
QQQ
722.050.08%
BTC/USD
80357.751.0695%
DIA
516.150.05%
GLD
401.490.08%
TLT
81.260.01%

Cadrenal Therapeutics Inc (CVKD) Stock Price, Quote, News & History

CVKDNASDAQ
Trade with Public
Trade with Public
$1.07
-0.05-4.46%
At close: Sep 18, 5:00 PM EST
$1.10
0.032.8%
After Hours: Sep 18, 7:27 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Cadrenal Therapeutics (CVKD) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$1.12
Close
$1.07
Volume / Avg.
113.70K / 426.45K
Day Range
$1.07 - $1.16
52 Wk Range
1.00 - 14.64
Market Cap
$3.92M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
27
Short Interest
2.79%
Days to Cover
1

Recent Cadrenal Therapeutics Inc News

Why Pyxis Tankers Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Shares of Pyxis Tankers Inc (NASDAQ:PXS) rose sharply in pre-market trading after the company reported better-than-expected earnings for the second quarter. The company posted quarterly earnings of 27 cents per
Avi Kapoor

Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.
Avi Kapoor

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.
Avi Kapoor

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-10.16M
Investing Cash Flow (TTM)
-412.00
Financing Cash Flow (TTM)
6.98M
Free Cash Flow (TTM)
-10.16M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-3.18M

Analyst Trends and Forecast

1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$437.32K
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.98
Earnings Yield % (TTM)
-435.71%
Earnings Yield % (FWD)
-291.07%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.15

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$2.39M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.12
Close
$1.07
Volume / Avg.
113.70K / 426.45K
Day Range
$1.07 - $1.16
52 Wk Range
1.00 - 14.64
Market Cap
$3.92M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
27
Short Interest
2.79%
Days to Cover
1

About

Sector
Health Care
Industry
Pharmaceuticals
Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to tr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cadrenal Therapeutics (CVKD) stock?

A

You can purchase shares of Cadrenal Therapeutics (NASDAQ:CVKD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cadrenal Therapeutics (CVKD) competitors?

Q

What is the forecast, or price target, for Cadrenal Therapeutics (CVKD) stock?

A

Cadrenal Therapeutics has a consensus price target of $36.50.

Q

What is the current price for Cadrenal Therapeutics (CVKD)?

A

The stock price for Cadrenal Therapeutics (NASDAQ: CVKD) is $1.1 last updated September 18, 2026 at 7:27 PM EDT.

Q

Does Cadrenal Therapeutics (CVKD) pay a dividend?

A

There are no upcoming dividends for Cadrenal Therapeutics.

Q

When is Cadrenal Therapeutics (NASDAQ:CVKD) reporting earnings?

A

Cadrenal Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cadrenal Therapeutics (CVKD) going to split?

A

There is no upcoming split for Cadrenal Therapeutics.

Q

What sector and industry does Cadrenal Therapeutics (CVKD) operate in?

A

Cadrenal Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved